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Abstract
Background: Recent in vitro evidence suggests a link between vitamin D status and the risk of tuberculosis (TB).
This study sought to examine the association between vitamin D status, parathyroid hormone (PTH) and the risk of
TB in a Vietnamese population.
Methods: The study was designed as a matched case-control study, which involved 166 TB patients (113 men and
53 women), who were age-and-sex matched with 219 controls (113 men and 106 women). The average age of
men and women was 49 and 50, respectively. TB was diagnosed by the presence of acid-fast bacilli on smears
from sputum, and the isolation of M. tuberculosis. All patients were hospitalized for treatment in a TB specialist
hospital. Controls were randomly drawn from the general community within the Ho Chi Minh, Vietnam.
25-hydroxyvitamin D [25(OH)D] and PTH was measured prior to treatment by an electrochemiluminescence
immunoassay (ECLIA) on a Roche Elecsys. A serum level of 25(OH)D below 30 ng/mL was deemed to be vitamin D
insufficient.
Results: The prevalence of vitamin D insufficiency was 35.4% in men with TB and 19.5% in controls (P = 0.01). In
women, there were no significant differences in serum 25(OH)D and serum PTH levels between TB patients and
controls. The prevalence of vitamin D insufficiency in women with TB (45.3%) was not significantly different from
those without TB (47.6%; P = 0.91). However, in both genders, serum calcium levels in TB patients were
significantly lower than in non-TB individuals. Smoking (odds ratio [OR] 1.25; 95% confidence interval [CI] 1.10 -
14.7), reduced 25(OH)D (OR per standard deviation [SD]: 1.14; 95% CI 1.07 - 10.7) and increased PTH (OR per SD
1.13; 95% CI 1.05 - 10.4) were independently associated with increased risk of TB in men.
Conclusion: These results suggest that vitamin D insufficiency was a risk factor for tuberculosis in men, but not in
women. However, it remains to be established whether the association is a causal relationship.
Background
Contrary to popular belief, tuberculosis (TB) is still an
on-going and important public health problem in the
world. In the year 2008 alone, there were 9.4 million
new cases of TB worldwide [1]. Moreover, according to
the World Health Organization, at present, one-third of
the world’sp o p u l a t i o ni si n f e c t e dw i t hT B ;o fw h i c h ,
34% are from Southeast Asian countries [2]. In Vietnam,
a Southeast Asian country, TB has historically been a
public health concern, due to a high prevalence and
incidence in the general population. Recent statistics
indicated that during 1997-2004 there were ~48,500
cases of TB (or 70 per 100,000 population), and the
incidence increased by around 0.2% per year, which
occurred mainly in rural areas [3]. However, it is not
clear why the incidence of TB in Vietnam has been on
the rise in recent years.
In recent years, several lines of evidence suggest a link
between vitamin D and TB [4-7]. The active form of vita-
min D (1,25(OH)2D3) has been shown to inhibit growth
of Mycobacterium tuberculosis (M. tuberculosis) through
stimulating cell-mediated immunity and activating
monocytes [6]. Studies in Gujarati Asians living in the
UK found that lower levels of 25(OH)D were associated
with an increased risk of pulmonary TB [8]. However, a
study in Indonesia found no significant difference in
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Nonetheless, a recent systematic review and meta-analy-
sis suggested that individuals with TB had lower levels of
25(OH)D than non-TB individuals [10]. The conclusion
is, however, not definite because the association could be
confounded by lifestyle factors and sunlight exposure
which were not considered in the analysis.
While the association between vitamin D and TB has
been studied in many Asian communities in Western
countries, few studies have been done in Asian popula-
tions. In Vietnam, a tropical country, we have recently
shown that the prevalence of vitamin D insufficiency in
Vietnam is high [11]. Given the biologic link between
vitamin D and immunity, we hypothesized that TB
patients had lower serum levels of vitamin D than
healthy individuals. This study was designed to test the
hypothesis by examining vitamin D status and parathyr-
oid hormone in the Vietnamese population.
Methods
Study design and subjects
The study setting was Ho Chi Minh City, Vietnam. The
City is located at 10°45’N, 106°40’E in the southeastern
region of Vietnam. The City, being close to the sea, has a
tropical climate, with an average humidity of 75%. There
are only two distinct seasons: the rainy season, with an
average rainfall of about 1,800 millimetres annually (about
150 rainy days per year), usually begins in May and ends
in late November; the dry season lasts from December to
April. The average temperature is 28°C (82°F), the highest
temperature sometimes reaches 39°C (102°F) around noon
in late April, while the lowest may fall below 16°C (61°F)
in the early mornings of late December. The present study
was taken place between April and May 2009.
The research protocol and procedures were approved
by the Medical Research Committees of the People’s
Hospital 115 and Pham Ngoc Thach University of Medi-
cine. All participants were provided with full information
about the study’s purpose and gave informed consent to
participate in the study, according to the principles of
medical ethics of the World Health Organization.
The study was designed as a case-control investiga-
tion, in which each case of TB was matched with 1 (for
men) or 2 controls (for women), with the matching vari-
ables being age and sex. The matching ratio 1:2 for
women was done to ensure the adequate of sample size
for detecting an association between vitamin D and TB.
The tolerance limit of age was 1 year. We used the
“greedy matching algorithm” (which has been imple-
mented in a SAS macro by Mayo Clinic) for matching
data [12]. The cases were recruited from Pham Ngoc
Thach Hospital (Ho Chi Minh City), which is a tertiary
teaching hospital specializing in TB treatment. The data
collection was undertaken as part of the National
Tuberculosis Program. During the period, all patients
admitted to the Hospital and diagnosed with TB, prior
to commencement of anti-TB treatment, were invited to
participate in the study.
TB was ascertained according to a standard procedure,
in which there was a presence of acid-fast bacilli (AFB)
on smears from sputum, and the isolation of M. tuber-
culosis on culture. A definitive diagnosis of TB was
made when patients met one of following criteria: (a) at
least two positive AFB smears from two different spu-
tum smears; (b) one positive AFB smear and positive
culture; and (c) one positive AFB smear and typical
result of lung TB infection on chest X-ray. AFB was
assessed using either fluore s c e n c em i c r o s c o p y( a u r a -
mine-rhodamine staining) or Ziehl-Neelsen staining
method. Sputum must contain 5,000 to 10,000 bacilli/
mL to be considered positive.
The control group was randomly recruited from var-
ious districts within the Ho Chi Minh City from another
study on vitamin D status in an urban population in
Vietnam, in which study procedures have been
described elsewhere [11]. Briefly, we approached com-
munity organizations, including churches and temples,
and obtained the list of members, and then randomly
selected individuals aged 18 or above. We sent a letter
of invitation to the selected individuals. Participants
were excluded from the study if they had diseases
deemed to affect to vitamin D metabolism such as
malabsorption syndrome, renal failure. In addition, indi-
viduals with prolonged immobility (over 2 months) were
not recruited to the study. The recruitment of cases and
controls was taken place at approximately the same
time.
Measurement of vitamin D
Prior to commencing TB treatment, fasting serum was
obtained for total calcium, creatinine, liver enzymes, and
parathyroid hormone (PTH) and 25-hydroxyvitamin D
[25(OH)D]. Concentration of 25(OH)D and PTH in
serum was measured by electrochemiluminescence
immunoassay (ECLIA) on a Roche Elecsys 10100/201
system (Roche Diagnosis Elecsys). This method can
measure the concentration of 25(OH)D in the range of
4-100 ng/ml (10-250 nmol/L), and PTH in the range
1.2-500 pg/ml (0.127-530 pmol/L). The sensitivity of the
assay is 1.5 ng/ml with an intraassay CV of 5.6% at 15.9
ng/ml and 11.6% at 58.9 ng/ml. The inter-assay CV at
these two levels was 9 and ~12%, respectively.
Data collection
A questionnaire relating to anthropometry, clinical his-
tory, lifestyle, physical activity, dietary habit, fracture
and falls, were developed and used in the data collec-
tion. The questionnaire collected anthropometric data
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the date of birth to the date of interview. Height without
shoes (in centimeters) was measured to the nearest 0.1
cm by a wall-mounted stadiometer. Weight, without
shoes or clothing, was measured (to the nearest 0.1 kg)
on an electronic scale. Body mass index (BMI) was then
d e r i v e da st h er a t i oo fw e i g h t( k g )o v e rh e i g h ts q u a r e d
(in m
2).
Each participant was asked to provide information on
current and past smoking habits. This was quantified in
terms of the number of pack-years consumed in each
ten-year interval age group. Alcohol intake in average
numbers of standard drinks per day, present as well as
within the last 5 years, was obtained.
Statistical analysis
Circulating vitamin D levels were classified into four
groups according to the following criteria: those unde-
tectable (< 15 ng/mL), those deficient (< 20 ng/mL),
those insufficient (< 30 ng/mL), and those sufficient (≥
30 ng/mL). The primary purpose of analysis was to
assess the association between vitamin D status and the
risk of TB. The main statistical model was the logistic
regression analysis, in which TB status was considered
the primary outcome. Circulating vitamin D level was
treated as a predictor. Clinical factors and lifestyle fac-
tors were considered as covariates. The association
between 25(OH)D and TB was expressed as odds ratio
and 95% confidence interval. The R program was used
for the statistical analysis [13].
Results
The study included 166 patients (113 men and 53
women) with TB, and 219 controls (113 men and 106
women). The average age of men and women was 49
and 50, respectively. By design, there was no significant
difference in age between TB and controls. As expected,
men and women with TB had lower body weight than
controls. About 78% of men with TB were smokers, and
this prevalence was significantly higher than in controls
(61%, P = 0.007). However, in women, there was no sig-
nificant difference in the prevalence of smoking between
TB patients and controls (P = 0.99). In women, the pre-
valence of alcohol use was 7.5%, which was significantly
higher than in controls (P = 0.01). In men, although the
prevalence of alcohol use in TB patients was higher
than in those without TB (64% vs 59%), the difference
was not statistically significant (P = 0.44).
In men, serum levels of 25(OH)D were lower (by 10%)
and serum levels of PTH were higher (by 20%) in
patients with TB than in controls. In women, there were
no significant differences in 25(OH)D and PTH between
TB patients and controls. However, in both genders,
serum calcium levels in TB patients were significantly
lower than in non-TB individuals (Table 1).
Using the criteria of 25(OH)D < 30 ng/mL, the preva-
lence of vitamin D insufficiency was 35.4% in men with
TB, and this prevalence was significantly higher than
controls (19.5%, P = 0.01; Figure 1). Using the criteria of
25(OH)D < 20 ng/mL, the prevalence of vitamin D defi-
ciency was 13.3% in men with TB, > 2-fold higher than
in men without TB (5.3%, P = 0.07). However, in
women, there was no significant difference in vitamin D
insufficiency (45% in TB vs 48% in non-TB; Figure 2) or
vitamin deficiency (21% vs 19%) between TB patients
and non-TB individuals. (Table 2).
Table 1 Clinical and demographic characteristics of study
participants
Variable Controls Tuberculosis MD (95%
CI)
P-
value
Women
N 106 53
Age (yr) 49(20) 50(20) -0.7(-7.4,
5.9)
0.831
Height (cm) 153(6) 154(4) -1.4(-3.1,
0.4)
0.118
Weight (kg) 51(7) 43(6) 7.7(5.4,
10.0)
<.001
Log[25(OH)D, ng/mL] 3.39
(0.18)
3.40(0.24) -0.01(-0.08,
0.05)
0.706
Log[PTH, pg/mL] 3.47
(0.39)
3.40(0.65) 0.07(-0.10,
0.23)
0.430
Serum calcium 2.35
(0.26)
2.11(0.38) 0.24(0.14,
0.35)
<.001
Use of corticosteroid (n;
%)
14(13.21) 6(11.32) 0.735
Use of alcohol (n; %) 0 4(7.55) 0.011
Ever smoking (n; %) 1(0.94) 1(1.89) 1.000
Men
N 113 113
Age (yr) 49(16) 50(20) -0.1(-4.2,
4.0)
0.949
Height (cm) 163(6) 154(4) -2.1(-3.6,
-0.5)
0.009
Weight (kg) 61(10) 43(6) 13.1(10.7,
15.5)
<.001
Log[25(OH)D, ng/mL] 3.60
(0.26)
3.49(0.24) 0.10(0.04,
0.17)
0.003
Log[PTH, pg/mL] 3.38
(0.38)
3.40(0.65) 0.23(0.11,
0.35)
<0.001
Serum calcium 2.34
(0.30)
2.11(0.38) 0.28(0.19,
0.36)
<.001
Use of corticosteroid (n;
%)
7(6.19) 9(8.04) 0.591
Use of alcohol (n; %) 67(59.29) 72(64.29) 0.441
Ever smoking (n; %) 69(61.06) 87(77.68) 0.007
Values are mean (standard deviation), unless otherwise specified
MD, mean difference.
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weight and lower serum levels of calcium were each
associated with increased risk of TB in women. How-
ever, in men, several risk factors were identified: smok-
ing, reduced height, weight, 25(OH)D, and calcium, and
increased PTH (Table 3). In the multiple logistic regres-
sion model, smoking, reduced 25(OH)D and increased
PTH were independently associated with increased risk
of TB in men. None of these factors was associated with
TB risk in women (Table 4).
Discussion
Although several lines of in-vitro evidence suggest a link
between vitamin D and immunity, the in-vivo associa-
tion between vitamin D status and tuberculosis is still a
contentious issue. In this study we found that vitamin D
insufficiency, as assessed by 25(OHD), was a risk factor
for TB in men, but not in women. This finding adds to
the growing evidence that vitamin D plays a role in the
regulation of M. tuberculosis.
The possible association between vitamin D and
tuberculosis was first reported more than 20 years ago
[14], but subsequent studies have yielded conflicting
findings. A number of studies in Gujarati Indian [8],
Indian, Pakistani, Somali, Afghan, Sri Lankan and Afri-
can residents in London [15], and African immigrants
living in Australia [16] all have shown that tuberculosis
had lower levels of 25(OH)D and higher prevalence of
vitamin D deficiency than non-TB individuals. Other
studies in Kenya [17] and West Africa [18] have also
Figure 1 Prevalence of vitamin D insufficiency (25(OH)D < 30 ng/mL) in controls (upper panel) and in cases with tuberculosis (lower
panel), men.
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compared to non-TB individuals. However, there was no
significant difference in 25(OH)D levels between TB
patients and controls in Indonesia [9] and Hong Kong
[19]. Nevertheless, a recent meta-analysis concluded that
TB patients had about 0.70 standard deviation (95% CI
0.42, 0.93) lower 25(OH)D concentration than non-TB
individuals [10]. In our study the effect size (in men)
was 0.42, which was in the lower range of the effect size
found in the meta-analysis. Thus, overall, our finding is
broadly consistent with most previous studies.
The observation that PTH was raised in TB patients is
probably not surprising, given the inverse relationship
between PTH and 25(OH)D [20,21]. However, in this
study we found that both reduced 25(OH)D levels and
Table 2 Prevalence of hypovitaminosis D in tuberculosis
and control by various 25(OH)D cut-off values
25(OHD) levels (ng/mL) Controls Tuberculosis P-value
Women (n) 106 53
<20 2(1.9) 3(5.7) 0.428
<25 20(19.1) 11(20.8) 0.966
<30 50(47.6) 24(45.3) 0.913
<50 (100.0) (100.0)
Men (n) 113 113
<20 2(1.8) 5(4.4) 0.442
<25 6(5.3) 15(13.3) 0.067
<30 22(19.5) 40(35.4) 0.011
<50 102(90.3) 110(97.4) 0.053
Number in bracket is percentage of group-specific total.
Figure 2 Prevalence of vitamin D insufficiency (25(OH)D < 30 ng/mL) in controls (upper panel) and in cases with tuberculosis (lower
panel), women.
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with an increased risk of TB, suggest that PTH may
have prognostic value for the assessment of TB risk. We
also found that in both genders, serum levels of calcium
was lower in TB patients than in controls. However, it
s h o u l db en o t e dt h a ti no u rs t u d yw ed i dn o tm e a s u r e
albumin, and uncorrected-for-albumin calcium levels
c o u l db ed r i v e nb ya l b u m i nlevels which are known to
be lower in TB patients. A previous study in African
population suggested that TB patients had higher serum
levels of calcium [17]. This is again consistent with the
physiologic understanding that the vitamin D hormone
system and parathyroid hormone are the principal regu-
lators of serum concentrations of calcium [21]. How-
ever, the finding raises the question that TB patients
may be at risk of increased bone loss and osteoporosis.
The observation of low 25(OH)D levels in TB patients
could be due to nutritional factors, however, this is unli-
kely. It is well-known that most (90%) of vitamin D is
synthesized in the skin under the influence of ultraviolet
sunlight of the sun, and only 10% of vitamin D is
o b t a i n e df r o mf o o d ,m a i n l ys a l m o n ,c o df i s h ,a n dd a i r y
products. In this study, we did not assess dietary cal-
cium intake, but typical Vietnamese diets in general
contain virtually very little salt water fishes (such as cod
fish and salmon) and little dairy and thus have low cal-
cium [22]. In a previous population based study, we
have shown that approximately 45% women and 20%
men were vitamin D insufficient. Thus, nutritional fac-
t o r sa r eu n l i k e l yt oc a u s et h eh i g hp r e v a l e n c eo fl o w
vitamin D in TB patients.
While low 25(OH)D and calcium levels in TB patients
could be a consequence of the disease, it is highly possi-
ble that vitamin D is an antecedent risk factors for TB.
The relationship between vitamin D and tuberculosis
may be mediated through two mechanisms: increased
production of cathelicidin and enhancement of macro-
phage ability. 1,25(OH)2D, the active form of vitamin D,
may enhance the production of LL-37, one of the class
of defensins-antimicrobial peptides of the cathelicidin
family, culminating in TB destruction [6,23]. Further-
more, vitamin D also restricts intracellular growth of TB
via enhancement of macrophage ability. Avoidance of
phago-lysosome fusion within the macrophage constitu-
tes a key survival mechanism of TB. The ability of
mycobacteria to hinder phagosomal progression, a con-
dition known as phagosome maturation arrest [24], is
partly achieved via its retention of the host’s tryptopha-
naspartate-containing coat protein (TACO/coronin-1)
[25]. Taken together, these data seem to suggest that
low vitamin D status is an antecedent risk factor for TB.
The sex-specific association between vitamin D and
TB is a notable finding, which deserves some remarks.
We found the association between vitamin D status and
the risk of TB in men, not in women. This finding is
actually consistent with a previous study in West Afri-
can population, in which the vitamin D - TB association
was only observed in men, not in women [18]. In that
study [18], women with TB appeared to have lower pre-
valence of vitamin D insufficiency than women without
TB (38% vs 41%). The underlying reason for this sex-
specific association is not clear. However, men in gen-
eral have higher risk of tuberculosis than women [26],
and this has been attributed to the sex-related differ-
ences in social economic and health care access [26]
which predispose men to a greater exposure to TB than
Table 3 Risk factors for tuberculosis, univariate analysis
Unit of
comparison
Women Men
OR (95% CI) OR (95% CI)
Age (y)* +10 1.00(0.97, 7.19) 1.00(0.96, 7.13)
Height (cm) +5 1.06(0.99, 8.41) 1.07(1.02,
8.84)
Weight -5 1.15(1.10,
11.00)
1.14(1.11,
10.59)
25(OH)D (ng/
mL)
-5 0.98(0.92, 6.61) 1.10(1.03,
9.56)
PTH (ng/L) -15 0.98(0.91, 6.60) 1.11(1.03,
9.81)
Serum calcium -0.3 1.16(1.09,
11.36)
1.20(1.14,
12.61)
Corticosteroid
use
yes 0.96(0.77, 6.35) 1.07(0.83, 8.77)
Alcohol use yes 1.98(1.25, 96.32) 1.05(0.92, 8.33)
Smoking yes 1.18(0.61, 12.05) 1.22(1.06,
13.17)
* Cases and controls were matched by age.
Table 4 Risk factors for tuberculosis, multivariable
analysis
Unit of
comparison
Women Men
OR (95% CI) OR (95% CI)
Model 1
Weight (kg) -5 1.15(1.11,
11.08)
1.13(1.10, 10.3)
25(OH)D (ng/
mL)
-1SD* 0.98(0.93, 6.74) 1.07(1.01, 8.52)
PTH (pg/mL) -15 0.96(0.90, 6.30) 1.10(1.03, 9.53)
Smoking yes 1.15(0.62,
10.97)
1.16(1.04,
11.40)
Model 2
25(OH)D (ng/
mL)
-1SD* 0.97(0.91, 6.55) 1.14(1.07,
10.70)
PTH (pg/mL) -15 0.97(0.91, 6.58) 1.13(1.05,
10.42)
Smoking yes 1.08(0.54, 9.10) 1.25(1.10,
14.67)
*1SD (ng/mL), 5 in women and 10 in men.
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a potential mediator that could account for the lower
risk of TB in women [27]; however, this hypothesis
remains to be tested in empirical studies.
The present study represents one of the largest studies
of vitamin D status and TB patients in Asian popula-
tions. The study was a matched case control design, and
as such, it increased the reliability of estimates of effect
size. The study population was highly homogeneous,
which reduced the effects of potential ethnic confoun-
ders that could compromise the estimates. Moreover,
the technique of measurement of 25(OH)D was a novel
Elecsys Vitamin D3 automated assay, which has been
shown to be a precise method for measuring vitamin D
over a wide reportable range in serum. Indeed, recent
studies have shown that measurement of 25(OH)D by
this method was highly concordant with the HPLC and
liquid chromatography tandem mass spectrometry
methods [28]. Nevertheless, the study has a number of
potential weaknesses. Because the study was a case-con-
trol design, no causal inferences could be made for the
observed association between vitamin D levels and TB.
We could not measure vitamin D2 (ergocalciferol) and
1,25D in this study; however, the occurrence of this vita-
min D (~10% of sera [29]) seems not to be a major pro-
b l e m .W ed i dn o ta s c e r t a i nt h et i m eo fe x p o s u r et o
sunlight among cases and controls. However, in this
study most TB patients were from rural areas, and rural
men normally have higher levels of sun exposure than
women. It could, therefore, be argued that the data
represented an underestimate of the effect of vitamin D
on TB, especially in men. The participants in the control
group was sampled from an urban population; but TB
patients were from both urban and rural areas, as a
result, the study’s finding may not be generalizable to
the rural population. Moreover, we did not systemati-
cally investigate active TB in the control group, and as a
result, we could not exclude the possibility of inclusion
of any TB cases in this group.
The finding of high prevalence of vitamin D insuffi-
ciency in TB patients has a number of clinical implica-
tions. Vitamin D in the form of cod liver oil and
sunlight exposure was once a therapy for tuberculosis
prior to the Robert Koch’s discovery of the etiology of
this disease. The association between vitamin D insuffi-
ciency and the risk of tuberculosis suggests that supple-
mentation of vitamin D may help prevent and reduce
the severity of tuberculosis. Indeed, a recent study [27]
has shown that the severity of TB at the end of treat-
ment was less for patients with normal vitamin D status
at baseline than for those with vitamin D insufficiency,
without adverse effects. However, the vitamin D dose
used in the intervention (100,000 IU) is probably too
low to warrant a clinical effect. These results taken
together suggest that low vitamin D status in TB
patients, whether cause or effect, might be an important
determinant of treatment outcome and comorbidities.
Conclusions
In summary, vitamin D insufficiency was associated with
an increased risk of tuberculosis in Vietnam, but the
association was observed in men, not in women. Con-
sidering findings from previous work, and given the cur-
rent epidemics of vitamin D insufficiency in the world
and in Vietnam, the present finding warrants further
studies to determine whether vitamin D supplementa-
tion can have a role in the prevention and treatment of
tuberculosis in developing countries.
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